SMi proudly announces the return of the 9th Annual Pre-Filled Syringes to London in Jan 2017!
The global market for pre-filled syringes will grow substantially over the next five years to reach sales of $6.6 billion, according to a new report from Smithers Rapra, a worldwide authority on the plastics and rubber industry supply chains. The report estimates that there are approximately 3.5 billion pre-filled syringe units produced a year and this will grow to 6.7 billion units by 2020.
The market has witnessed continual advancements in device design with enhanced safety and usability by patients through human factor engineering. Nonetheless, challenges surrounding biologic drug stability, manufacturing and competition from other drug delivery technologies remain key concerns amongst pharma and medical device manufacturers.
Emulating on SMi’s successful PFS series, this must-attend event returns to London. Join us today to discuss with your industry colleagues to accelerate PFS development and innovation!
- Day 1
- 8:30
- Registration & Coffee
- 9:00
- Chairman's Opening Remarks
- Alphons Fakler, Group Head Risk Management, Novartis Pharma
- 9:10
- Regulatory aspects of pre-filled syringes - Latest regulatory updates from MHRA
- Vikas Jaitely , Deputy Manager and Senior Pharmaceutical Assessor Licensing Division, Medicines and Healthcare Products Regulatory Agency (MHRA)
- 9:50
- New technologies for pre-filled syringes – streamlining innovation
- Alexander Jung, Senior Manager Technology and Innovation, Drug Delivery & Devices, Boehringer Ingelheim
- 9:50
- New technologies for pre-filled syringes – streamlining innovation
- Christian Dechant, Primary Packaging Director, Boehringer Ingelheim
- 10:30
- Components and systems selection strategies for pre-filled syringes, risk mitigation, performance and quality
- Christa Jansen-Otten, Director Global Product Management Prefilled Systems and Delivery, West Pharmaceutical Services
- 11:10
- Morning Coffee & Networking Break
- 11:40
- Device design implications of increasing dose volume on injection time and patient factors
- David Blakely, Device Development Manager, GSK
- 12:20
- Combination products: a need for flexible and customisable drug delivery devices
- Adrien Tisserand, Category Manager - Parenteral, Nemera
- 13:00
- Networking Lunch
- 14:10
- Engineering of delivery system integration for biologics and primary containers
- Paolo Mangiagalli, Senior Director - PFS Platform, Sanofi
- 14:50
- Introduction of an innovative and groundbreaking in-line X-ray inspection technology in a pre-fillable syringe manufacturing line
- Matteo Falgari, Sales Manager PFS, Nipro PharmaPackaging
- 15:30
- Afternoon Tea & Networking Break
- 16:00
- Ocular injection - PFS development
- Markus Hemminger, Senior Engineer Pre-Filled Syringes, F. Hoffmann-La Roche
- 16:40
- Panel Discussion: Combination products – challenges and opportunities
- Alphons Fakler, Group Head Risk Management, Novartis Pharma
- 16:40
- Panel Discussion: Combination products – challenges and opportunities
- Serkan Oray, Senior Director, Device & Technology, UCB
- 16:40
- Panel Discussion: Combination products – challenges and opportunities
- David Ottolangui, Device Technology Director, GSK
- 16:40
- Panel Discussion: Combination products – challenges and opportunities
- Ed Cahill, Senior Director, Technical and Scientific Affairs, Teva
- 17:00
- Chairman’s Closing Remarks and Close of Day One
- Day 2
- 8:30
- Registration & Coffee
- 9:00
- Chairman's Opening Remarks
- Alphons Fakler, Group Head Risk Management, Novartis Pharma
- 9:10
- Regulatory updates – recent guidelines on Human Factors Engineering
- Nick Stones, Fellow, Human Factors Engineer, Novartis
- 9:50
- Formulation and drug delivery challenges for mid-sized companies
- Sachin Dubey, Head of Formulation , Glenmark Pharmaceuticals
- 10:30
- An insight into the preferences for injection devices in rheumatoid arthritis patients
- Richard Featherstone, Managing Director, Medical Device Usability
- 11:10
- Morning Coffee & Networking Break
- 11:40
- An update on Polymer-based pre-fillable syringes addressing the challenges of therapeutic proteins
- William Dierick, Director Technology Development, Terumo Pharmaceutical Solutions
- 12:20
- Siliconisation - influence on functionality
- Vincent Cazanave, Pre-Fillable Syringe Engineering Device Development, Roche
- 13:00
- Networking Lunch
- 14:10
- OXYCAPT multilayer plastic syringes having excellent oxygen and water vapor barrier
- Kenichiro Usuda, Researcher, Advanced Business Development Division, Mitsubishi Gas Chemical Company
- 14:50
- From filling to packaging
- Andreas Kerschbaumer, Facilitator Compouding, Filling & Inspection, Sandoz
- 15:30
- Afternoon Tea & Networking Break
- 16:00
- Stability of Pharmaceutical Proteines in contact with Cyclo Olefin Polymer (COP) Syringes
- Reinhard Scheller, Commercial Manager Cyclo Olefin Polymers - COP, Zeon Europe GmbH
- 16:40
- Panel Discussion: The future of parenteral drug delivery - moving from drug delivery devices to therapy management ecosystems
- Alphons Fakler, Group Head Risk Management, Novartis Pharma
- 16:40
- Panel Discussion: The future of parenteral drug delivery - moving from drug delivery devices to therapy management ecosystems
- Ignace Wallaert, Principal Scientist Packaging Development, Janssen Pharmaceutica
- 17:20
- Chairman's Closing Remarks and Close Day Two
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBookOther tasks
